These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7767482)

  • 41. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Freezing of Apheresis Platelet Concentrates in 6% Dimethyl Sulfoxide: The First Preliminary Study in Turkey.
    Yılmaz S; Çetinkaya RA; Eker İ; Ünlü A; Uyanık M; Tapan S; Pekoğlu A; Pekel A; Erkmen B; Muşabak U; Yılmaz S; Avcı İY; Avcu F; Kürekçi E; Eyigün CP
    Turk J Haematol; 2016 Mar; 33(1):28-33. PubMed ID: 25912150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation of Platelet Concentrates for Research and Transfusion Purposes.
    Greening DW; Simpson RJ; Sparrow RL
    Methods Mol Biol; 2017; 1619():31-42. PubMed ID: 28674875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-transfusion non-invasive quality assessment of stored platelet concentrates.
    Bellhouse EL; Inskip MJ; Davis JG; Entwistle CC
    Br J Haematol; 1987 Aug; 66(4):503-8. PubMed ID: 3663507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
    Sandgren P; Shanwell A; Gulliksson H
    Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of platelet concentrates.
    Sweeney JD; Holme S; Heaton A
    Immunol Invest; 1995; 24(1-2):353-70. PubMed ID: 7713596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogen reduction technologies: The pros and cons for platelet transfusion.
    Magron A; Laugier J; Provost P; Boilard E
    Platelets; 2018 Jan; 29(1):2-8. PubMed ID: 28523956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Past and future approaches to assess the quality of platelets for transfusion.
    Maurer-Spurej E; Chipperfield K
    Transfus Med Rev; 2007 Oct; 21(4):295-306. PubMed ID: 17900491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo properties of various types of platelets.
    Rebulla P
    Vox Sang; 1998; 74 Suppl 2():217-22. PubMed ID: 9704448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
    Tynngård N; Trinks M; Berlin G
    Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro platelet quality in storage containers used for pediatric transfusions.
    Weiss S; Scammell K; Levin E; Culibrk B; Zolfaghari S; Gyöngyössy-Issa MI; Acker JP
    Transfusion; 2012 Aug; 52(8):1703-14. PubMed ID: 22257224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
    Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
    Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet storage solution affects on the accuracy of laboratory tests for platelet function: a multi-laboratory study.
    VandenBroeke T; Dumont LJ; Hunter S; Nixon J; Murphy S; Roger J; Herschel L; AuBuchon JP; Gulliksson H; Dengler T; Hornsey V; Prowse C;
    Vox Sang; 2004 Apr; 86(3):183-8. PubMed ID: 15078253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of processing characteristics of photochemically treated pooled platelets: target requirements for the INTERCEPT Blood System comply with routine use after process optimization.
    Picker SM; Speer R; Gathof BS
    Transfus Med; 2004 Jun; 14(3):217-23. PubMed ID: 15180813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality control of riboflavin-treated platelet concentrates using Mirasol® PRT system: Polish experience.
    Lachert E; Kubis J; Antoniewicz-Papis J; Rosiek A; Woźniak J; Piotrowski D; Przybylska Z; Mikołowska A; Marschner S; Łętowska M
    Adv Clin Exp Med; 2018 Jun; 27(6):765-772. PubMed ID: 29877637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viability and function of 8-day-stored apheresis platelets.
    Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
    Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.